Yes, and they should collect tissue samples to determine genetics and phenotypic differences in these outlier patients and follow up studies. And yes, it seems that there is an over expression of PDL one in CTC’s that are an evolutionary mechanism that allows for DNA repair to happen as these migrating to cells are in the blood and heading off to seed other tumors.